Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic MelanomaMengshi Li, Michael K. Schultz, Katherine N. Gibson‐Corley et al.|Molecular Pharmaceutics|2019Cited by 32
The role of cellular redox imbalance, ER-stress, and autophagy in adaptation of metastatic melanoma to MAPK pathway inhibitionSomya Kapoor, Ling Yang, Douglas R. Spitz et al.|Unknown|2018Cited by 0